Barclays Upgrades Astrana Health to Overweight, Raises Price Target to $50

Benzinga Newsdesk www.benzinga.com Positive 90.1%

Neg 0% Neu 0% Pos 90.1%

Barclays analyst Andrew Mok upgrades Astrana Health (NASDAQ:ASTH) from Equal-Weight to Overweight and raises the price target from $37 to $50.